SCHEMBL21998489

SCHEMBL21998489

CC(C)=CC(=O)Nc1ccc(/C=C/c2ccc3c(c2)OCO3)cc1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.76
TP53 P04637 1/20 0.76
KDM4E B2RXH2 7/20 0.70
MAPT P10636 4/20 0.70
EPHX2 P34913 2/20 0.67
ALDH1A1 P00352 5/20 0.62
MEN1 O00255 3/20 0.62
KMT2A Q03164 3/20 0.62
NPC1 O15118 3/20 0.62
RAB9A P51151 3/20 0.62
TRPV1 Q8NER1 2/20 0.59
CYP1A2 P05177 1/20 0.55
CYP3A4 P08684 1/20 0.55
CYP2C9 P11712 1/20 0.55
HPGD P15428 1/20 0.55
CYP2C19 P33261 1/20 0.55
HDAC6 Q9UBN7 1/20 0.54
PKM P14618 1/20 0.52
LMNA P02545 1/20 0.52
MAPK1 P28482 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21933245 0.87 KDM4E (0.81) SMN1; SMN2KDM4EMAPTEPHX2ALDH1A1
SCHEMBL21998497 0.84 EPHX2 (0.67) SMN1; SMN2TP53KDM4EMAPTEPHX2
SCHEMBL21998488 0.82 KDM4E (0.78) SMN1; SMN2KDM4EMAPTEPHX2ALDH1A1
SCHEMBL19097940 0.82 EPHX2 (0.70) SMN1; SMN2TP53KDM4EMAPTEPHX2
SCHEMBL21998487 0.81 MAPT (0.76) SMN1; SMN2KDM4EMAPTEPHX2ALDH1A1
SCHEMBL21933247 0.81 EPHX2 (0.69) SMN1; SMN2KDM4EMAPTEPHX2ALDH1A1
SCHEMBL21933255 0.81 EPHX2 (0.69) SMN1; SMN2KDM4EMAPTEPHX2ALDH1A1
SCHEMBL21933291 0.81 EPHX2 (1.00) SMN1; SMN2KDM4EMAPTEPHX2ALDH1A1
SCHEMBL21998490 0.80 TRPV1 (0.80) SMN1; SMN2KDM4EMAPTEPHX2ALDH1A1
SCHEMBL21996664 0.80 KDM4E (0.74) SMN1; SMN2KDM4EMAPTEPHX2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10829466-B2 Stilbene derivative and preparation method thereof BEIJING INSTITUTE OF TECHNOLOGY (CN) 2020-11-10 US disclosed
US-20200148662-A1 NOVEL STILBENE DERIVATIVE AND PREPARATION METHOD THEREOF BEIJING INSTITUTE OF TECHNOLOGY (CN) 2020-05-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10829466-B2 Stilbene derivative and preparation method thereof STS, F12, GLB1 SMN1; SMN2 3805/4885TP53 2507/4885KDM4E 4389/4885
US-20200148662-A1 NOVEL STILBENE DERIVATIVE AND PREPARATION METHOD THEREOF STS, F12, STK38L SMN1; SMN2 3934/4885TP53 2467/4885KDM4E 4442/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.